Description

Genetic factors influencing individual responses to phytocannabinoid therapy in epilepsy are explored. Polymorphisms in cannabinoid receptors and metabolizing enzymes may predict treatment outcomes.

Figure 31

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 31: Genetic factors influencing individual responses to phytocannabinoid therapy in epilepsy are explored. Polymorphisms in cannabinoid receptors and metabolizing enzymes may predict treatment outcomes.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Genetic factors influencing individual responses to phytocannabinoid therapy in epilepsy are explored. Polymorphisms in cannabinoid receptors and metabolizing enzymes may predict treatment outcomes." />
  <figcaption>Figure 31. Genetic factors influencing individual responses to phytocannabinoid therapy in epilepsy are explored. Polymorphisms in cannabinoid receptors and metabolizing enzymes may predict treatment outcomes.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Preuves associées

CBD pour Insomnie

Note A · 103 études